RS20060504A - Combination of deramciclane and opoids as analgesics - Google Patents

Combination of deramciclane and opoids as analgesics

Info

Publication number
RS20060504A
RS20060504A YUP-2006/0504A YUP20060504A RS20060504A RS 20060504 A RS20060504 A RS 20060504A YU P20060504 A YUP20060504 A YU P20060504A RS 20060504 A RS20060504 A RS 20060504A
Authority
RS
Serbia
Prior art keywords
analgesic
deramciclane
opoids
analgesics
combination
Prior art date
Application number
YUP-2006/0504A
Other languages
English (en)
Inventor
Gabor Gigler
Gyorgy Gabor Levay
Istvan Gacsalyi
Laszlo Gabor Harsing
Gabor Szenasi
Original Assignee
Egis Gyogyszergyar Nyrt.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyrt., filed Critical Egis Gyogyszergyar Nyrt.,
Publication of RS20060504A publication Critical patent/RS20060504A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Predmetni pronalazak se odnosi na kobinovani analgetski farmaceutski preparat koji sadrži, kao komponentu: A) (lR,2S,4R)-(-)-2-[N,N-(dimetilaminoetoksi)]-2-fenil-1,7,7 -trimetilbiciklo[2.2.1 ]heptan ili njegovu farmakološki prihvatljivu adicionu so kiseline i kao komponentu B) morfijum, analgetik opoidnog tipa i/ili analgetik neopoidnog tipa u smeši sa pogodnim farmaceutskim nosiocima i/ili dodatnim sredstvima Deramciklan pojačava analgetsko dejstvo morfijuma.
YUP-2006/0504A 2004-03-12 2004-03-12 Combination of deramciclane and opoids as analgesics RS20060504A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU2004/000021 WO2005087213A1 (en) 2004-03-12 2004-03-12 Combination of deramciclane and opoids as analgesics

Publications (1)

Publication Number Publication Date
RS20060504A true RS20060504A (en) 2008-09-29

Family

ID=34957272

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2006/0504A RS20060504A (en) 2004-03-12 2004-03-12 Combination of deramciclane and opoids as analgesics

Country Status (19)

Country Link
US (1) US20070244102A1 (sr)
EP (1) EP1734940B1 (sr)
JP (1) JP2007528891A (sr)
CN (1) CN1946386A (sr)
AT (1) ATE410156T1 (sr)
AU (1) AU2004317128A1 (sr)
BR (1) BRPI0418631A (sr)
CA (1) CA2559487A1 (sr)
CZ (1) CZ2006623A3 (sr)
DE (1) DE602004017062D1 (sr)
EA (1) EA010691B1 (sr)
HR (1) HRP20060325A2 (sr)
IL (1) IL177734A0 (sr)
IS (1) IS8546A (sr)
MX (1) MXPA06010388A (sr)
NO (1) NO20064645L (sr)
RS (1) RS20060504A (sr)
SK (1) SK50812006A3 (sr)
WO (1) WO2005087213A1 (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU231055B1 (hu) * 2015-10-09 2020-04-28 Egis Gyógyszergyár Zrt. Deramciklan és nem-szteroid gyulladásgátló gyógyszerek kombinációjának alkalmazása jobb gyulladáscsökkentő hatás elérésére
HU230962B1 (hu) * 2015-10-28 2019-06-28 Egis Gyógyszergyár Zrt. Palbociclib sók
US11478467B2 (en) 2017-05-04 2022-10-25 Sreenivasarao Vepachedu Targeted drug rescue with novel compositions, combinations, and methods thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652270A (en) * 1994-07-01 1997-07-29 Egis Gyogyszergyar Rt Pharmaceutical compositions containing bicycloheptane ether amines and a process for the preparation thereof
HU226061B1 (en) * 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use

Also Published As

Publication number Publication date
US20070244102A1 (en) 2007-10-18
HRP20060325A2 (en) 2007-02-28
DE602004017062D1 (de) 2008-11-20
EA010691B1 (ru) 2008-10-30
IS8546A (is) 2006-10-03
EP1734940B1 (en) 2008-10-08
NO20064645L (no) 2006-12-08
JP2007528891A (ja) 2007-10-18
AU2004317128A1 (en) 2005-09-22
MXPA06010388A (es) 2007-03-07
CN1946386A (zh) 2007-04-11
IL177734A0 (en) 2006-12-31
SK50812006A3 (sk) 2007-03-01
ATE410156T1 (de) 2008-10-15
WO2005087213A1 (en) 2005-09-22
EA200601665A1 (ru) 2007-04-27
CA2559487A1 (en) 2005-09-22
CZ2006623A3 (cs) 2007-01-24
BRPI0418631A (pt) 2007-05-29
EP1734940A1 (en) 2006-12-27

Similar Documents

Publication Publication Date Title
UA90518C2 (ru) Фармацевтическая композиция в форме таблетки, которая имеет улучшеное всасывание при трансбукальном введение, которая содержит наркотический активный ингредиент и амин
BR0316948A (pt) Composto, formulação farmacêutica, e, uso de um composto
TW200605870A (en) Topical methadone compositions and methods for using the same
WO2002042462A3 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
BRPI0417771A (pt) heterociclos azabicìclicos como moduladores de receptor canabinóides
EP2279732A3 (en) Compounds and compositions for delivering active agents
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
WO2003045306A3 (en) Phenoxy amine compounds and compositions for delivering active agents
EP2332526A3 (en) Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
EP2308479A3 (en) Compounds and compositions for delivering active agents
CL2004001050A1 (es) Compuesto derivado de 3'-[4-oxo-3-{[(ciclopropil o 2,2,2-trifluoroetil)amino]carbonil}-1,8-naftiridin-1(4h)-il]-3-sustituido-1-1'-bifenil-4-il; composicion farmaceutica; y uso en el tratamiento o prevencion de asma, bronquitis cronica, enfermedad pul
SG149872A1 (en) Antagonists of the bradykinin b1 receptor
SE0102440D0 (sv) New compound
IL166596A0 (en) Salt of morphine-6-glucoronide
WO2004112838A3 (en) Codrugs of diclofenac
IL177734A0 (en) Combination of deramciclane and opoids as analgesics
BE2016C017I2 (sr)
UA83903C2 (ru) Комбинированная фармацевтическая композиция дерамциклана и опиоидов как обезболивающее средство
WO2002055022A3 (en) Active metabolite of antifungal compound
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
CA2534338A1 (en) Transdermal formulation comprising an opioid analgesic and an aloe composition
WO2005121074A3 (en) Processes for the preparation of sertraline hydrochloride
WO2007069033A3 (en) Pharmaceutical compositions comprising dexibuprofen, an opiate analgesic and paracetamol
EP1260221A3 (en) Combination treatment for depression and anxiety
WO2006036956A3 (en) Therapeutic regimen for treating cancer using quassinoids and other chemotherapeutic agents